Advertisement

Gastric Bypass pp 247-253 | Cite as

Marginal Ulceration After (Laparoscopic) Roux-en-Y Gastric Bypass: Pathophysiology, Diagnostics, Treatment, and Prevention

  • U. K. Coblijn
  • B. A. van Wagensveld
  • S. M. Lagarde
  • S. M. M. de Castro
Chapter
  • 39 Downloads

Abstract

Laparoscopic Roux-en-Y gastric bypass (LRYGB) is one of the most performed bariatric procedures worldwide. One of the long-term complications is a marginal ulcer (MU). This is a potentially severe complication which can lead to massive bleeding or perforation. The pathophysiology is still unclear but most likely multifactorial and due to exposure of the jejunum to gastric acid, corpora aliena, and tension at the anastomosis. Most patients suffer from epigastric burn or abdominal pain, but a significant portion does not have any symptoms at all, possibly increasing the risk of a pouch perforation or bleeding. Around two thirds of the patients with MU can be sufficiently treated with proton pump inhibitors (PPIs), whereas patients who suffer from a perforation or bleeding are more likely to need endoscopy or even surgery as treatment. The development of MU can be prevented with a prophylactic course of PPIs.

Keywords

Anastomotic ulcer Bariatric surgery Bleeding ulcer Gastric acid Gastric bypass Marginal ulcer Morbid obesity Perforation Roux-en-Y gastric bypass PPIs 

References

  1. 1.
    Capella JF, Capella RF. Staple disruption and marginal ulceration in gastric bypass procedures for weight reduction. Obes Surg. 1996;6(1):44–9.PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Rasmussen JJ, Fuller W, Ali MR. Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients. Surg Endosc. 2007;21(7):1090–4.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Csendes A, Burgos AM, Altuve J, Bonacic S. Incidence of marginal ulcer 1 month and 1 to 2 years after gastric bypass: a prospective consecutive endoscopic evaluation of 442 patients with morbid obesity. Obes Surg. 2009;19(2):135–8.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Sapala JA, Wood MH, Sapala MA, Flakee TM Jr. Marginal ulcer after gastric bypass: a prospective 3-year study of 173 patients. Obes Surg. 1998;8(5):505–16.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Sanyal AJ, Sugerman HJ, Kellum JM, Engle KM, Wolfe L. Stomal complications of gastric bypass: incidence and outcome of therapy. Am J Gastroenterol. 1992;87(9):1165–9.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427–36.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    World Health Organisation. Obesity and overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
  8. 8.
    Caruana JA, McCabe MN, Smith AD, Panemanglore VP, Sette CD. Risk of massive upper gastrointestinal bleeding in gastric bypass patients taking clopidogrel. Surg Obes Relat Dis. 2007;3(4):443–5.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Felix EL, Kettelle J, Mobley E, Swartz D. Perforated marginal ulcers after laparoscopic gastric bypass. Surg Endosc. 2008;22(10):2128–32.CrossRefGoogle Scholar
  10. 10.
    Kalaiselvan R, Exarchos G, Hamza N, Ammori BJ. Incidence of perforated gastrojejunal anastomotic ulcers after laparoscopic gastric bypass for morbid obesity and role of laparoscopy in their management. Surg Obes Relat Dis. 2012;8(4):423–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Garrido AB Jr, Rossi M, Lima SE Jr, Brenner AS, Gomes CA Jr. Early marginal ulcer following Roux-en-Y gastric bypass under proton pump inhibitor treatment: prospective multicentric study. Arq Gastroenterol. 2010;47(2):130–4.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Coblijn UK, Goucham AB, Lagarde SM, Kuiken SD, van Wagensveld BA. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review. Obes Surg. 2014;24(2):299–309.PubMedCrossRefGoogle Scholar
  13. 13.
    Coblijn UK, Lagarde SM, de Castro SM, Kuiken SD, van Wagensveld BA. Symptomatic marginal ulcer disease after Roux-en-Y gastric bypass: incidence, risk factors and management. Obes Surg. 2015;25:805–11.PubMedCrossRefGoogle Scholar
  14. 14.
    Capella JF, Capella RF. Gastro-gastric fistulas and marginal ulcers in gastric bypass procedures for weight reduction. Obes Surg. 1999;9(1):22–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Siilin H, Wanders A, Gustavsson S, Sundbom M. The proximal gastric pouch invariably contains acid-producing parietal cells in Roux-en-Y gastric bypass. Obes Surg. 2005;15(6):771–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Mason EE, Printen KJ, Blommers TJ, Lewis JW, Scott DH. Gastric bypass in morbid obesity. Am J Clin Nutr. 1980;33(2 Suppl):395–405.PubMedCrossRefGoogle Scholar
  17. 17.
    Printen KJ, Scott D, Mason EE. Stomal ulcers after gastric bypass. Arch Surg. 1980;115(4):525–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Sapala JA, Wood MH, Sapala MA, Schuhknecht MP, Flake TM Jr. The micropouch gastric bypass: technical considerations in primary and revisionary operations. Obes Surg. 2001;11(1):3–17.PubMedCrossRefGoogle Scholar
  19. 19.
    Wittgrove AC, Clark GW, Tremblay LJ. Laparoscopic gastric bypass, Roux-en-Y: preliminary report of five cases. Obes Surg. 1994;4(4):353–7.CrossRefGoogle Scholar
  20. 20.
    Wittgrove AC, Clark GW, Schubert KR. Laparoscopic gastric bypass, Roux-en-Y: technique and results in 75 patients with 3–30 months follow-up. Obes Surg. 1996;6(6):500–4.CrossRefGoogle Scholar
  21. 21.
    Hedberg J, Hedenstrom H, Sundbom M. Wireless pH-metry at the gastrojejunostomy after Roux-en-Y gastric bypass: a novel use of the BRAVO system. Surg Endosc. 2011;25(7):2302–7.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Mason EE, Munns JR, Kealey GP, Wangler R, Clarke WR, Cheng HF, et al. Effect of gastric bypass on gastric secretion. Am J Surg. 1976;131(2):162–8.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Hedberg J, Hedenstrom H, Nilsson S, Sundbom M, Gustavsson S. Role of gastric acid in stomal ulcer after gastric bypass. Obes Surg. 2005;15(10):1375–8.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Coblijn UK, Lagarde SM, Tuynman JB, van Meyel JJ, van Wagensveld BA. Delayed massive bleeding two years after Roux-en-Y gastric bypass. JSLS. 2013;17(3):476–80.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    D’Hondt MA, Pottel H, Devriendt D, Van RF, Vansteenkiste F. Can a short course of prophylactic low-dose proton pump inhibitor therapy prevent stomal ulceration after laparoscopic Roux-en-Y gastric bypass? Obes Surg. 2010;20(5):595–9.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Coblijn UK, Lagarde SM, de Castro SM, Kuiken SD, van Tets WF, van Wagensveld BA. The influence of prophylactic proton pump inhibitor treatment on the development of symptomatic marginal ulceration in Roux-en-Y gastric bypass patients: a historic cohort study. Surg Obes Relat Dis. 2016;12(2):246–52.CrossRefGoogle Scholar
  27. 27.
    Azagury DE, Abu Dayyeh BK, Greenwalt IT, Thompson CC. Marginal ulceration after Roux-en-Y gastric bypass surgery: characteristics, risk factors, treatment, and outcomes. Endoscopy. 2011;43(11):950–4.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Bendewald FP, Choi JN, Blythe LS, Selzer DJ, Ditslear JH, Mattar SG. Comparison of hand-sewn, linear-stapled, and circular-stapled gastrojejunostomy in laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2011;21(11):1671–5.PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Sacks BC, Mattar SG, Qureshi FG, Eid GM, Collins JL, Barinas-Mitchell EJ, et al. Incidence of marginal ulcers and the use of absorbable anastomotic sutures in laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2(1):11–6.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Vasquez JC, Wayne OD, Farrell TM. Fewer gastrojejunostomy strictures and marginal ulcers with absorbable suture. Surg Endosc. 2009;23(9):2011–5.PubMedCrossRefGoogle Scholar
  31. 31.
    Suggs WJ, Kouli W, Lupovici M, Chau WY, Brolin RE. Complications at gastrojejunostomy after laparoscopic Roux-en-Y gastric bypass: comparison between 21- and 25-mm circular staplers. Surg Obes Relat Dis. 2007;3(5):508–14.PubMedCrossRefGoogle Scholar
  32. 32.
    Erim T, Cruz-Correa MR, Szomstein S, Velis E, Rosenthal R. Prevalence of Helicobacter pylori seropositivity among patients undergoing bariatric surgery: a preliminary study. World J Surg. 2008;32(9):2021–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Ramaswamy A, Lin E, Ramshaw BJ, Smith CD. Early effects of Helicobacter pylori infection in patients undergoing bariatric surgery. Arch Surg. 2004;139(10):1094–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Csendes A, Burgos AM, Smok G, Beltran M. Endoscopic and histologic findings of the foregut in 426 patients with morbid obesity. Obes Surg. 2007;17(1):28–34.PubMedCrossRefGoogle Scholar
  35. 35.
    Clark GW, Wittgrove AC. Laparoscopic gastric bypass in a porcine model. J Laparoendosc Surg. 1996;6(3):197–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Hayllar J, Bjarnason I. NSAIDs, Cox-2 inhibitors, and the gut. Lancet. 1995;346(8990):1629.PubMedCrossRefGoogle Scholar
  37. 37.
    Cashman JN. The mechanisms of action of NSAIDs in analgesia. Drugs. 1996;52(Suppl 5):13–23.PubMedCrossRefGoogle Scholar
  38. 38.
    Wilson JA, Romagnuolo J, Byrne TK, Morgan K, Wilson FA. Predictors of endoscopic findings after Roux-en-Y gastric bypass. Am J Gastroenterol. 2006;101(10):2194–9.PubMedCrossRefGoogle Scholar
  39. 39.
    Csendes A, Torres J, Burgos AM. Late marginal ulcers after gastric bypass for morbid obesity. Clinical and endoscopic findings and response to treatment. Obes Surg. 2011;21(9):1319–22.PubMedCrossRefGoogle Scholar
  40. 40.
    Dallal RM, Bailey LA. Ulcer disease after gastric bypass surgery. Surg Obes Relat Dis. 2006;2(4):455–9.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    ASMBS. Safety and effectiveness of newer bariatric and metabolic surgery procedures. asmbs org 2012 June 1 [cited 2015 Jan 15]. Available from: URL: https://asmbs.org/resources/studies-weigh-in-on-safety-and-effectiveness-of-newer-bariatric-and-metabolic-surgery-procedure.
  42. 42.
    Gumbs AA, Duffy AJ, Bell RL. Incidence and management of marginal ulceration after laparoscopic Roux-Y gastric bypass. Surg Obes Relat Dis. 2006;2(4):460–3.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Racu C, Dutson EP, Mehran A. Laparoscopic gastrojejunostomy revision: a novel approach to intractable marginal ulcer management. Surg Obes Relat Dis. 2010;6(5):557–8.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Madan AK, DeArmond G, Ternovits CA, Beech DJ, Tichansky DS. Laparoscopic revision of the gastrojejunostomy for recurrent bleeding ulcers after past open revision gastric bypass. Obes Surg. 2006;16(12):1662–8.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Frezza EE, Herbert H, Ford R, Wachtel MS. Endoscopic suture removal at gastrojejunal anastomosis after Roux-en-Y gastric bypass to prevent marginal ulceration. Surg Obes Relat Dis. 2007;3(6):619–22.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Jiang HP, Lin LL, Jiang X, Qiao HQ. Meta-analysis of hand-sewn versus mechanical gastrojejunal anastomosis during laparoscopic Roux-en-Y gastric bypass for morbid obesity. Int J Surg. 2016;32:150–7.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Kang X, Zurita-Macias L, Hong D, Cadeddu M, Anvari M, Gmora S. A comparison of 30-day versus 90-day proton pump inhibitor therapy in prevention of marginal ulcers after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2016;12(5):1003–7.PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Ying VW, Kim SH, Khan KJ, Farrokhyar F, D’Souza J, Gmora S, et al. Prophylactic PPI help reduce marginal ulcers after gastric bypass surgery: a systematic review and meta-analysis of cohort studies. Surg Endosc. 2015;29(5):1018–23.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • U. K. Coblijn
    • 1
  • B. A. van Wagensveld
    • 2
  • S. M. Lagarde
    • 3
  • S. M. M. de Castro
    • 2
  1. 1.Department of SurgeryVrije Universiteit Medical CenterAmsterdamThe Netherlands
  2. 2.Department of SurgeryOnze Lieve Vrouwe GasthuisAmsterdamThe Netherlands
  3. 3.Department of SurgeryErasmus Medical CenterRotterdamThe Netherlands

Personalised recommendations